Abstract
In this chapter, we show the presence of tissue-type plasminogen activator (t-PA), urokinase-type plasminogen activator (u-PA), and plasminogen activator inhibitor-1 (PAI-1) in nasal mucosa. It is suggested that t-PA synthesized in mucous cells is promptly secreted and modifies the watery nasal discharge in allergic rhinitis and that u-PA activity may help with the passage of large amounts of rhinorrhea by reducing its viscosity. Furthermore, we clarify the relation between fibrinolytic components and the pathology of allergy, particularly during the development of nasal allergy and nasal tissue changes. Wild-type (WT) mice can develop nasal allergy for ovalbumin (OVA) sensitization, but PAI-1-deficient mice (PAI-1-/-) cannot. The production of specific immunoglobulins IgG1 and IgE in the serum and production of interleukins IL-4 and IL-5 in splenocyte culture supernatant increased significantly in WT-OVA mice. In PAI-1-/- mice, these reactions were absent, and specific IgG2a in serum and interferon-γ in splenocyte culture medium increased significantly. Histopathologically, there was marked goblet cell hyperplasia and eosinophil infiltration into the nasal mucosa in WT-OVA mice, but these were absent in PAI-1-/- mice. These results indicate that the immune response in WT-OVA mice can be classified as a dominant Th2 response, which would promote collagen deposition. In contrast, the Th2 response in PAI-1-/- mice was down-regulated and the immune response shifted from Th2-dominant reaction to a Th1-dominant one. Taken together, these findings suggest that PAI-1 plays an important role not only in thrombolysis but also in the immune response.
Chapter PDF
References
Liu YX, Peng XR, Ny T (1991) Tissue-specific and time-coordinated hormone regulation of plasminogen-activator-inhibitor type 1 and tissue-type plasminogen activator in the rat ovary during gonadotropin-induced ovulation. Eur J Biochem 195:549–555
Schneiderman J, Bordin GM, Engelberg I, et al (1995) Expression of fibrinolytic genes in atherosclerotic abdominal aortic aneurysm wall. J Clin Invest 96:639–645
Bugge TH, Kombrinck KW, Flick MJ, et al (1996) Loss of fibrinogen rescues mice from the pleiotropic effects of plasminogen deficiency. Cell 87:709–719
Carmeliet P, Moons L, Pioplis V, et al (1997) Impaired arterial neointima formation in mice with disruption of the plasminogen gene. J Clin Invest 99:200–208
Oh CK, Ariue B, Alban RF, et al (2002) PAI-1 promotes extracellular matrix deposition in the airways of a murine asthma model. Biochem Biophys Res Commun 294: 1155–1160
Gyetko MR, Sud S, Chen GH, et al (2002) Urokinase-type plasminogen activator is required for the generation of a type 1 immune response to pulmonary Cryptococcus neoformans infection. J Immunol 168:801–809
Gyetko MR, Sud S, Chensue SW (2004) Urokinase-deficient mice fail to generate a type 2 immune response following schistosomal antigen challenge. Infect Immun 72:461–467
Sejima T, Madoiwa S, Mimuro J, et al (2004) Expression profiles of fibrinolytic components in nasal mucosa. Histochem Cell Biol 122:61–73
Larsen K, Maat MPM, Jespersen J (1997) Plasminogen activators in human nasal polyps and mucosa. Rhinology 35:175–177
Åkerlund A, Greiff L, Andersson M, et al (1993) Mucosal exudation of fibrinogen in coronavirus-induced common colds. Acta Otolaryngol 113:642–648
Sadwey M, Loskutoff DJ (1991) Regulation murine plasminogen activator inhibitor 1 gene expression in vivo: tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-α, and transforming growth factor-β. J Clin Invest 88:1346–1353
Jensen PJ, Rodeck U (1993) Autocrine/paracrine regulation of keratinocyte urokinase plasminogen activator through the TGF-α/EGF receptor. J Cell Physiol 155:133–139
Holgate ST (1998) Airway remodeling. Eur Respir Rev 8:1007–1011
Bousquet J, Jeffery PK, Busse WB, et al (2000) Asthma: from bronchoconstriction to airway remodeling. Am J Respir Crit Care Med 61:1720–1745
Collen D (1999) The plasminogen (fibrinolytic) system. Thromb Haemost 82:259–270
Sanai A, Nagata H, Konno A (1999) Extensive interstitial collagen deposition on the basement membrane zone in allergic nasal mucosa. Acta Otolaryngol 119:473–478
Boulet L, Laviolette M, Turcotte H, et al (1997) Bronchial subepithelial fibrosis correlates with airway responsiveness to methacholine. Chest 112:45–52
Sejima T, Madoiwa S, Mimuro J, et al (2005) Protection of plasminogen activator inhibitor-1 deficient mice from nasal allergy. J Immunol 174:8135–8143
Hattori N, Degen JL, Sisson TH, et al (2000) Bleomycin-induced pulmonary fibrosis in fibrinogen-null mice. J Clin Invest 106:1341–1350
Mosmann TR, Cherwinski H, Bond MW, et al (1986) Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136:2348–2357
Sandler NG, Mentink-Kane MM, Cheever AW, et al (2003) Global gene expression profiles during acute pathogen-induced pulmonary inflammation reveal divergent roles for Th1 and Th2 responses in tissue repair. J Immunol 171:3655–3667
Del Prete G, Maggi E, Parronch P, et al (1988) IL-4 is an essential factor for the IgE synthesis induced in vitro by human T cell clones and their supernatants. J Immunol 140:4193–4198
Ueda A, Chandswang N, Ovary Z (1990) The action of interleukin-4 on antigen-specific IgG1 and IgE production by interaction in vivo primed B cells and carrier-specific cloned Th2 cells. Cell Immunol 128:31–34
Lopez AF, Sanderson CJ, Gamble JR, et al (1988) Recombinant human interleukin 5 is a selective activator of human eosinophil function. J Exp Med 167:219–224
Yamaguchi Y, Hayashi Y, Sugama Y, et al (1988) Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival: IL-5 as an eosinophil chemotactic factor. J Exp Med 167:1737–1742
Deng G, Curriden SA, Hu G, et al (2001) Plasminogen activator inhibitor-1 regulates cell adhesion by binding to the somatomedin B domain of vitronectin. J Cell Physiol 189:23–33
Tarui T, Andronicos N, Czekay RP, et al (2003) Critical role of integrin α5β1 in urokinase (uPA)/urokinase receptor (uPAR, CD87) signaling. J Biol Chem 278:29863–29872
Dano K, Andreasen PA, Grondahl-Hansen J, et al (1985) Plasminogen activators, tissue degradation and cancer. Adv Cancer Res 44:139–266
Cho SH, Hall IP, Wheatley M, et al (2001) Possible role of the 4G/5G polymorphism of the plasminogen activator inhibitor 1 gene in the development of asthma. J Allergy Clin Immunol 108:212–214
Bucková D, Izakovicova Hollá L, Vácha J (2002) Polymorphism 4G/5G in the plasminogen activator inhibitor-1 (PAI-1) gene is associated with IgE-mediated allergic diseases and asthma in the Czech population. Allergy 57:446–448
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer
About this chapter
Cite this chapter
Sejima, T., Sakata, Y. (2008). Role of Fibrinolysis in the Nasal System. In: Tanaka, K., Davie, E.W., Ikeda, Y., Iwanaga, S., Saito, H., Sueishi, K. (eds) Recent Advances in Thrombosis and Hemostasis 2008. Springer, Tokyo. https://doi.org/10.1007/978-4-431-78847-8_23
Download citation
DOI: https://doi.org/10.1007/978-4-431-78847-8_23
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-78846-1
Online ISBN: 978-4-431-78847-8
eBook Packages: MedicineMedicine (R0)